FMF50: A score for assessing outcome in familial Mediterranean fever

Annals of the Rheumatic Diseases

Volumn 73, Issue 5, 2014, Pages 897-901

  Ozen, Seza ^a   Demirkaya, Erkan ^b   Duzova, Ali ^a   Erdogan, Ozlem ^c   Erken, Eren ^d   Gul, Ahmet ^e   Kasapcopur, Ozgur ^e   Kasifoglu, Timucin ^f   Kisacik, Bunyamin ^g   Ozdogan, Huri ^e   Tunca, Mehmet ^h   Acikel, Cengizhan ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f GAZI UNIVERSITY   (Turkey)

^g GAZIANTEP UNIVERSITY   (Turkey)

^h DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DELPHI STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FMF50; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

FAMILIAL MEDITERRANEAN FEVER; OUTCOMES RESEARCH; TREATMENT;

ADOLESCENT; ADULT; AREA UNDER CURVE; COLCHICINE; DELPHI TECHNIQUE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; REGISTRIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897969408     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204719     Document Type: Article

References (18)

1. Hull KM, Shoham N, Chae JJ, et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003;15:61-9 (Pubitemid 36021025)
2. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol 2013. doi:10.1038/ nrrheum.2013.174 [Epub ahead of print 19 Nov 2013]
3. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011;7:105-12
4. Ozturk MA, Kanbay M, Kasapoglu B, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 2011;29:S77-86
5. ter Haar N, Lachmann H, Özen S, et al. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 2013;72:678-85
6. Meinzer U, Quartier P, Alexandra JF, et al. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 2011;41:265-71
7. Özen S, Bilginer Y, Ayaz NA, et al. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. J Rheumatol 2011;38:516-18
8. Kalkan G, Demirkaya E, Acikel CH, et al. Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford) 2012;51:743-8
9. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nursing 2000;32:1008-15
10. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85 (Pubitemid 27452541)
11. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009;48:395-8
12. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9
13. Kallinich T, Haffner D, Niehues T, et al. Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 2007;119:e474-e83
14. Zemer D, Livneh A, Danon YL, et al. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991;34:973-7
15. Tunca M, Tankurt E, Akbaylar H, et al. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol 1997;36:1005-8
16. Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998;25:2445-9 (Pubitemid 28551865)
17. Piram M, Frenkel J, Gattorno M, et al. A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference. Ann Rheum Dis 2011;70:309-14
18. Mor A, Shinar Y, Zaks N, et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64. (Pubitemid 41111472)